Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06503510
NA

Role of Interleukin-13 Pathways on Pain and Itch Sensitivity

Sponsor: Aalborg University

View on ClinicalTrials.gov

Summary

Atopic dermatitis (AD) is as chronic, inflammatory skin disorder affecting 20% of the world's population. Intense itch and skin pain are the main symptoms. Research has shown that the proteins interleukins are involved in inflammation and itch in atopic dermatitis. The medicinal product called Lebrikizumab, used for treatment of AD, has shown to block the interleukin called IL-13. The purpose of this experiment is to evaluate the role of IL-13 in itch in both healthy subjects and people with atopic dermatitis.

Official title: The Role of the Interleukin-13 Pathways on Pain and Itch Sensitivity in Patients With Atopic Dermatitis and Healthy Volunteers

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2025-01-06

Completion Date

2026-12-31

Last Updated

2025-06-04

Healthy Volunteers

Yes

Conditions

Interventions

OTHER

Histamine

A small drop of histamine dihydrochloride (1%, in saline) will be applied to a previously determined area on the volar forearm followed by a prick through the drop.

OTHER

Cowhage

Approximately 30-35 cowhage spicules will be manually inserted into the subject's skin.

OTHER

bovine adrenal medulla (BAM8-22)

A small drop of BAM8-22 solution will be applied to a previously determined area on the volar forearm followed by a prick through the drop.

Locations (3)

Aalborg University

Gistrup, Aalborg, Denmark

CNAP

Gistrup, Aalborg, Denmark

Aalborg University

Aalborg, Denmark, Denmark